secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amylyx Pharmaceuticals, Inc. (AMLX)
CIK:        0001658551
Form:       8-K
Filed at:   2022-06-09T23:59:59+00:00
Accession:  0001193125-22-171014
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Amylyx shareholders elect Class I directors and ratify Deloitte as auditor at 2022 annual meeting
--------------------------------------------------------------------------------

- Justin Klee elected Class I director with 42,100,898 votes for, 1,607,476 withheld.
- Isaac Cheng elected Class I director with 41,946,619 votes for, 1,761,755 withheld.
- Ratification of Deloitte & Touche as independent auditor for FY2022 approved with 43,834,729 votes for, 72,090 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1658551/000119312522171014/0001193125-22-171014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1658551/000119312522171014/d362452d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-171014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer